LONG-TERM OUTCOMES FROM THE PHASE II L-MIND STUDY OF TAFASITAMAB (MOR208) PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Gilles Salles, 293691

AN IMMUNE-RELATED PROGNOSTIC CLASSIFIER ASSOCIATED WITH DIFFUSELARGE B-CELL LYMPHOMA MICROENVIRONMENT

EHA Library, Liang Wang, 293692

CLINICOPATHOLOGICAL CHARACTERISTICS AND MYC STATUS DETERMINE TREATMENT OUTCOME IN PLASMABLASTIC LYMPHOMA: A MULTI-CENTER STUDY OF 76 CONSECUTIVE PATIENTS

EHA Library, Hanno M Witte, 293693

PROOF OF CONCEPT FOR TIPIFARNIB IN RELAPSED OR REFRACTORY ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA (AITL): PRELIMINARY RESULTS FROM AN OPEN-LABEL, PHASE 2 STUDY

EHA Library, Dr. Thomas Witzig, 293694

EARLY RESPONSE OBSERVATION IN ALK KINASE INHIBITORS COMBINED WITH/WITHOUT VINBLASTINE IN PEDIATRIC REFRACTORY/RELAPSED ALK+ ANAPLASTIC LARGE CELL LYMPHOMA

EHA Library, Yonghong Zhang, 293695

OUTCOME OF DIFFUSE LARGE B-CELL LYMPHOMA ASSOCIATED WITH HEPATITIS C VIRUS IN ELDERLY PATIENTS: RESULTS OF THE PROSPECTIVE 'ELDERLY PROJECT' BY THE FONDAZIONE ITALIANA LINFOMI (FIL)

EHA Library, Annalisa Arcari, 293696

FDG PET DELTA SUVMAX FOLLOWING 4 CYCLES RATHER THAN 2 CYCLES OF R-CHOP PREDICTS STRONGLY FOR REFRACTORY DISEASE IN AGGRESSIVE B CELL NON-HODGKIN LYMPHOMA

EHA Library, Joel Wight, 293697

NO SEX-RELATED DIFFERENCE IN RELATIVE SURVIVAL AMONG ELDERLY PATIENTS WITH DLBCL TREATED WITH R-CHOP: A CONTEMPORARY, NATIONWIDE, POPULATION-BASED STUDY IN THE NETHERLANDS

EHA Library, Mujde Durmaz, 293698

EXPLORATION OF TUMOR BIOPSY GENE SIGNATURES TO UNDERSTAND THE ROLE OF THE TUMOR MICROENVIRONMENT IN OUTCOMES TO LISOCABTAGENE MARALEUCEL (LISO-CEL)

EHA Library, N. Eric Olson, 293699

REAL-WORLD RESULTS OF ANTI-CD19 CAR T CELLS USE FOR PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA IN LYON SUD HOSPITAL

EHA Library, Pierre Sesques, 293700

OUTPATIENT TREATMENT WITH LISOCABTAGENE MARALEUCEL (LISO-CEL) ACROSS A VARIETY OF CLINICAL SITES FROM THREE ONGOING CLINICAL STUDIES IN RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA

EHA Library, Carlos Bachier, 293701

DIFFUSE LARGE B CELL LYMPHOMA INVOLVING OSSEOUS SITES – RESPONSE ASSESSMENT BY PET/CT AND LONG-TERM OUTCOMES

EHA Library, Salma Ahsanuddin, 293702

TREATMENT STRATIFICATION IN B-CELL PTLD AFTER SOLID ORGAN TRANSPLANTATION BY TRANSPLANTED ORGAN, INTERNATIONAL PROGNOSTIC INDEX (IPI) AND RESPONSE TO RITUXIMAB: INTERIM RESULTS FROM THE PTLD-2 TRIAL

EHA Library, Heiner Zimmermann, 293703

RISK PROFILING OF FIRST-LINE DLBCL PATIENTS BY MEASURING CIRCULATING TUMOR DNA

EHA Library, Aparna Raval, 293704

COMBINATION TREATMENT WITH COPANLISIB, A PI3K INHIBITOR, AND GEMCITABINE IN RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMAS (RR-PTCL); A MULTICENTER, OPEN-LABEL, PHASE 1/2 TRIAL (COSMOS TRIAL)

EHA Library, Deok-Hwan Yang, 293705

HOW MUCH IS TOO MUCH FOR EARLY-STAGE EXTRANODAL NK/T-CELL LYMPHOMA: A MULTI-CENTRE RETROSPECTIVE STUDY COMPARING P-GEMOX REGIMEN VERSUS EPOCHL REGIMEN

EHA Library, Liang Wang, 293706

SUBCUTANEOUS EPCORITAMAB (GEN3013; CD3XCD20) IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA: DOSE-ESCALATION DATA FROM A PHASE 1/2 TRIAL

EHA Library, Martin Hutchings, 293707

CHARACTERISTICS AND OUTCOME OF BIOPSY-PROVEN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS AFTER SOLID ORGAN TRANSPLANTATION: A REAL LIFE PICTURE ANNO 2020.

EHA Library, vibeke vergote, 293708

MONOTHERAPY (M-TX) ACTIVITY WITH THE FIRST CD20-TARGETED IMMUNOTOXIN, MT-3724, IN SUBJECTS (SBS) WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL)

EHA Library, Roger Waltzman, 293709

DOSE-ADJUSTED EPOCH AND RITUXIMAB (DA-EPOCH-R) FOR THE TREATMENT OF DUAL EXPRESSOR AND DOUBLE HIT DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, MULTICENTER ITALIAN STUDY

EHA Library, Anna Dodero, 293710

A NOVEL SIX-GENE BASED PROGNOSTIC MODEL FOR PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Liang Wang, 293711

AUTOLOGOUS STEM CELL TRANSPLANTATION FOR UNTREATED TRANSFORMED INDOLENT B-CELL LYMPHOMA IN FIRST REMISSION: AN INTERNATIONAL, MULTI-CENTER PROPENSITY MATCHED STUDY

EHA Library, Collin Chin, 293712

PROGNOSTIC FACTORS (PF) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL) TREATED WITH RITUXIMAB-CHOP (RCHOP) ± RADIOTHERAPY (RT): IDENTIFICATION OF VERY LOW RISK SUBGROUPS

EHA Library, Theodoros Vassilakopoulos, 293713

PROGNOSTIC IMPACT OF 18F-FDG PET-CT IN PATIENTS WITH AGGRESSIVE B CELL LYMPHOMA TREATED WITH ANTI-CD19 CAR T CELLS

EHA Library, Pierre Sesques, 293714

EFFICACY AND SAFETY OF SINGLE AGENT ORAL SELINEXOR IN PATIENTS WITH PRIMARY REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): A POST-HOC ANALYSIS OF THE SADAL STUDY

EHA Library, Josee. M Zijlstra, 293715

RELAPSED OR REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA IN SPAIN: A PRELIMINARY ANALYSIS OF THE GELTAMO-LDR2LSTUDY

EHA Library, Mariana Beatriz Bastos, 293716

HOW TO TREAT ELDERLY PATIENTS OVER 80 YEARS WITH DIFFUSE LARGE B-CELL LYMPHOMA: ALL BENEFIT FROM RITUXIMAB AND SELECTED ONES FROM R-CHOP

EHA Library, Prokop Vodicka, 293717

RISK OF HEPATITIS B REACTIVATION AND CYTOMEGALOVIRUS RELATED INFECTIONS WITH MOGAMULIZUMAB: A RETROSPECTIVE STUDY OF INTERNATIONAL PHARMACOVIGILANCE DATABASE

EHA Library, Abhishek KUMAR, 293718

HIGH-DOSE METHOTREXATE (HDMTX) IN LYMPHOMA; IDENTIFYING METHOTREXATE LEVEL AT WHICH COMPLICATIONS ARE MORE LIKELY

EHA Library, Darragh O'Donoghue, 293719

REAL-WORLD DATA ON FRONTLINE INTENSIFICATION PROVIDING SURVIVAL BENEFITS IN PATIENTS WITH HIGHER-RISK PRIMARY CNS LYMPHOMA

EHA Library, Hao Yuan Wang, 293720

CLINICOPATHOLOGIC FEATURES & OUTCOMES OF DE NOVO TRANSFORMED INDOLENT LYMPHOMA.

EHA Library, Collin Chin, 293721

THE DIFFERENCE IN PREDICTIVE VALUE BETWEEN BONE MARROW INVOLVEMENT DETECTED USING FDG PET-CT AND BONE MARROW EXAMINATION IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Hanae Ida, 293722

CIRCULATING MICRORNAS IS A POTENTIAL PROGNOSTIC BIOMARKER IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Yan Ma, 293723

TISLELIZUMAB (BGB-A317) FOR RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMAS: SAFETY AND EFFICACY RESULTS FROM A PHASE 2 STUDY

EHA Library, Pier Luigi Zinzani, 293724

CHARACTERIZATION OF CYTOKINE RELEASE SYNDROME AND NEUROLOGICAL EVENTS IN THE PHASE 1 TRANSCEND NHL 001 TRIAL OF LISOCABTAGENE MARALEUCEL FOR PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA

EHA Library, M. Lia Palomba, 293725

CLONAL HEMATOPOIESIS IN PATIENTS WITH HIGH-GRADE B-CELL LYMPHOMA IS ASSOCIATED WITH INFERIOR OUTCOME

EHA Library, Panagiotis Baliakas, 293726

A WEST-EUROPEAN COHORT OF PATIENTS WITH NK/T-CELL LYMPHOMA, A POPULATION-BASED ANALYSIS.

EHA Library, Jaap Van Doesum, 293727

DDGP, AN EFFECTIVE AND TOLERABLE REGIMEN FOR RELAPSED/REFRACTORY EXTRANODAL NATURAL KILLER/T-CELL LYMPHOMA

EHA Library, 欣 王, 293728

FIBRINOGEN AND FERRITIN MAY HELP TO DETECT SEVERE ICANS AT AN EARLY STAGE AFTER ANTI-CD19 CAR-T CELL THERAPY

EHA Library, Pierre Sesques, 293729

POLATUZUMAB-VEDOTIN IN COMBINATION WITH RITUXIMAB/BENDAMUSTINE IN A GREEK MULTICENTER COHORT OF RELAPSED/REFRACTORY AGGRESSIVE B-CELL-NON-HODGKIN LYMPHOMA PATIENTS:REAL-LIFE DATA ON EFFICACY & SAFETY

EHA Library, Maria Dimou, 293731

APPARENT DIFFUSION COEFFICIENT AS A VALUABLE QUANTITATIVE PARAMETER FOR PREDICTING CLINICAL OUTCOMES IN PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA

EHA Library, Ju-Hyung Kim, 293732

EFFECT OF PRIOR THERAPY ON THE EFFICACY AND SAFETY OF ORAL SELINEXOR IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): A POST-HOC ANALYSIS OF THE SADAL STUDY

EHA Library, George Follows, 293733

REFLECT REAL-WORLD EVIDENCE: NON-INTERVENTIONAL, PROSPECTIVE STUDY UPDATE ON THE EFFICACY AND SAFETY OF SANDOZ BIOSIMILAR RITUXIMAB FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Manfred Welslau, 293734

BIOMARKER IDENTIFICATION IN RELAPSED/REFRACTORY NON-GERMINAL CENTER B-CELL–LIKE DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH ZANUBRUTINIB

EHA Library, Haiyan Yang, 293735

ALX148, A CD47 BLOCKER, IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) NON-HODGKIN LYMPHOMA (NHL).

EHA Library, Tae Min Kim, 293736

BIANCA: PHASE 2, SINGLE-ARM, GLOBAL TRIAL TO DETERMINE EFFICACY AND SAFETY OF TISAGENLECLEUCEL IN PEDIATRIC/YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Veronique Minard-Colin, 293737

THE OPTIMAL DOSE OF PEGYLATED LIPOSOMAL DOXORUBICIN FOR FIRST- LINE TREATMENT OF DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Shenmiao Yang, 293738

POLATUZUMAB-VEDOTIN COMBINED WITH IMMUNOCHEMOTHERAPY IN R/R PATIENTS WITH DLBCL: A RETROSPECTIVE, NON-INTERVENTIONAL, REAL-LIFE STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGIC DISEASES

EHA Library, Dino Dujmovic, 293739

CLINICAL OUTCOMES OF PATIENTS WITH ADULT T-CELL LEUKEMIA-LYMPHOMA IN A NON-ENDEMIC METROPOLITAN AREA: A RETROSPECTIVE ANALYSIS OF THE POPULATION-BASED OSAKA CANCER REGISTRY

EHA Library, Shigeo Fuji, 293740

THE PROGNOSTIC SIGNIFICANCE OF HEPATITIS B VIRUS ANTIBODY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Shunfeng Hu, 293741

REAL WORLD POPULATION-BASED EXPLORATION OF THE PATHOLOGY SUBTYPING AND TREATMENT-MODALITIES OF DIFFUSE LARGE B-CELL LYMPHOMA IN BELGIUM IN RELATION TO SURVIVAL

EHA Library, Willem Daneels, 293742

TREATMENT OUTCOME OF N/K T-CELL LYMPHOMA IN MEXICAN PATIENTS: A SINGLE THIRD LEVEL CENTER RETROSPECTIVE ANALYSIS

EHA Library, Katheryn Garzón Velásquez, 293743

PRELIMINARY RESULTS OF RESPONSE-ADAPTED STUDY OF IBRUTINIB, TEMOZOLOMIDE, ETOPOSIDE, DOXIL, DEXAMETHASONE, AND RITUXIMAB (TEDDI-R) IN AGGRESSIVE B-CELL LYMPHOMAS WITH SECONDARY INVOLVEMENT OF THE CNS

EHA Library, Mark Roschewski, 293744

PHASE I/II STUDY OF AVADOMIDE (CC-122) IN COMBINATION WITH R-CHOP FOR NEWLY DIAGNOSED DLBCL

EHA Library, Alejandro Martin, 293745

A PHASE IB/II STUDY OF IDASANUTLIN IN COMBINATION WITH OBINUTUZUMAB OR RITUXIMAB IN PATIENTS WITH FOLLICULAR LYMPHOMA OR DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Martin Trepel, 293746

SALVAGE TREATMENT WITH HUMANIZED CART CELLS FOR DIFFUSED LARGE B-CELL LYMPHOMA AFTER THE FAILURE OF MURINE ANTI-CD19-CART CELL THERAPY

EHA Library, Shaomei Feng, 293747

RETREATMENT OF PATIENTS WITH REFRACTORY LARGE B CELL LYMPHOMA WITH AXICABTAGENE CILOLEUCEL (AXI-CEL) IN ZUMA-1

EHA Library, Javier Munoz, 293748

SURVIVAL AMONG PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH SINGLE AGENT ORAL SELINEXOR IN THE SADAL STUDY

EHA Library, Marie Maerevoet, 293749

PHASE 2A OPEN-LABEL STUDY OF MT-3724, A NOVEL CD20-TARGETING ENGINEERED TOXIN BODY, IN COMBINATION WITH LENALIDOMIDE (LEN) IN SUBJECTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA (B-NHL)

EHA Library, Roger Waltzman, 293750

CHARACTERISTICS AND CLINICAL SIGNIFICANCE OF GENE MUTATIONS IN RELAPSED OR REFRACTORY PRIMARY MEDIASTINAL B-CELL LYMPHOMA

EHA Library, Yuelu Guo, 293751

FERTILITY AFTER DOSE-ADJUSTED EPOCH-R IN PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA - UKRAINIAN EXPERIENCE

EHA Library, Yana Stepanishyna, 293752

PATTERNS OF CARE AND CLINICAL OUTCOMES OF PERIPHERAL T-CELL LYMPHOMA IN THE FRONT-LINE SETTING IN FRANCE, THE UNITED KINGDOM, AND GERMANY

EHA Library, Ajibade Ashaye, 293753

CLINICAL CHARACTERISTICS AND SURVIVAL OF EXTRANODAL NATURAL KILLER/T-CELL LYMPHOMA: A SINGLE CENTER 12-YEAR RETROSPECTIVE ANALYSIS.

EHA Library, Jianda Hu, 293754

CORRELATION OF PD-L1 EXPRESSION WITH RESPONSE - PHASE I/II TRIAL OF PEMBROLIZUMAB AND ROMIDEPSIN IN RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA

EHA Library, Melody Becnel, 293755

ADVERSE EVENTS AND CLINICAL BURDEN ASSOCIATED WITH CHEMOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY EBV+ PTLD FOLLOWING SOT: A RETROSPECTIVE CHART REVIEW STUDY FROM GERMANY AND FRANCE

EHA Library, Heiner Zimmermann, 293756

TISLELIZUMAB (BGB-A317) FOR RELAPSED/REFRACTORY EXTRANODAL NK/T-CELL LYMPHOMA: PRELIMINARY EFFICACY AND SAFETY RESULTS FROM A PHASE 2 STUDY

EHA Library, Huiqiang Huang, 293757

REAL-WORLD TREATMENT PATTERNS AMONG PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH CD19-DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY (CAR T)

EHA Library, Jessica J Jalbert, 293758

REGN1979 INDUCES TRANSIENT INCREASE IN CYTOKINE LEVELS, T-CELL ACTIVATION, AND CIRCULATING T-CELL REDUCTION, BUT NO SUSTAINED EFFECTS ON T-CELLS OR CYTOKINE RELEASE

EHA Library, Jurriaan Brouwer-Visser, 293759

ZANUBRUTINIB (BGB-3111) IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA

EHA Library, Jianfeng Zhou, 293760

RITUXIMAB, LENALIDOMIDE AND ACALABRUTINIB (R2A) FOR RELAPSED/REFRACTORY AGGRESSIVE B-CELL LYMPHOMA: INTERIM ANALYSIS REPORTING GOOD TOLERABILITY AND POTENTIAL DURABLE RESPONSE

EHA Library, Youngil Koh, 293761

UTILITY OF THE KYOTO PROGNOSTIC INDEX IN HIGHER-RISK DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS TREATED WITH UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A SUPPLEMENTARY ANALYSIS OF JCOG0908

EHA Library, Tsutomu Kobayashi, 293762

COMBINATION OF BRENTUXIMAB-VEDOTIN AND IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE (ICE) IN RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA

EHA Library, Zoe Van de Wyngaert, 293763

EPIDEMIOLOGY AND TREATMENT PATTERNS OF HHV-8-NEGATIVE/IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE IN THE ERA OF INTERLEUKIN-6 DIRECTED THERAPY.

EHA Library, Sudipto Mukherjee, 293764

CAN RADIOTHERAPY BE SAFELY OMITTED IN PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA WHO ACHIEVE COMPLETE METABOLIC RESPONSE AFTER CHEMOIMMUNOTHERAPY? A RETROSPECTIVE ANALYSIS FROM A SINGLE CENTER.

EHA Library, Ayman Sayyed, 293765

25 CASES OF NEUROLYMPHOMATOSIS, A SINGLE-INSTITUTION EXPERIENCE OVER 13 YEARS; CLINICAL FEATURES, DIAGNOSIS, AND PROGNOSIS

EHA Library, Kentaro Narita, 293766

PROGNOSTIC IMPACT AND CLINICAL FEATURES OF IDH2R172 MUTATED ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA: A MULTICENTER RETROSPECTIVE STUDY

EHA Library, Marcello Riva, 293767

EARLY DEATHS IN CHILDHOOD BURKITT'S LYMPHOMA; A MAJOR CHALLENGE IN DEVELOPING COUNTRIES

EHA Library, Hanafy Hafez, 293768

A DECADE OF REAL-WORLD EXPERIENCE WITH R-CHOP IN DIFFUSE LARGE B CELL LYMPHOMA – IS EFS24 THE GOAL?

EHA Library, Pedro Chorão, 293769

IMPACT OF RELATIVE DOSE INTENSITY ON SURVIVAL IN ELDERLY PATIENTS AGED 80 YEARS AND OLDER WITH DIFFUSE LARGE B-CELL LYMPHOMA.

EHA Library, Shin Lee, 293770

IS THERE AN IMPACT OF THE FIRST-LINE CHEMOTHERAPY REGIMEN ON THE OUTCOME OF HIGH-GRADE B-CELL LYMPHOMA WITH C-MYC REARRANGEMENT (ALONE OR IN COMBINATION WITH BVL-2 AND/OR BCL-6)

EHA Library, Simon Favre, 293771

DA-R-EPOCH AS FRONT-LINE TREATMENT OF ELDERLY PATIENTS WITH HIGH-RISK DIFFUSE LAGRE B-CELL LYMPHOMA (DLBCL): A REAL-LIFE SINGLE-CENTER STUDY

EHA Library, Igor Aurer, 293772

INTERIM RESULTS OF A PHASE 1/2 STUDY OF LONCASTUXIMAB TESIRINE (LONCA) COMBINED WITH IBRUTINIB IN ADVANCED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) OR MANTLE CELL LYMPHOMA (MCL)

EHA Library, Julien Depaus, 293773

NEW TRICKS FOR OLD DRUGS: COMBINATION OF RITUXIMAB, ALBUMIN-BOUND PACLITAXEL AND PEGYLATED LIPOSOMAL DOXORUBICIN IN THE TREATMENT OF RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Liang Wang, 293774

AUTOLOGOUS 4-1BB-CART THERAPY FOR B CELL LYMPHOMA AND MULTIPLE MYELPMA WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT

EHA Library, Peihao Zheng, 293775

LENALIDOMIDE-RITUXIMAB IN HIGH RISK RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE

EHA Library, Diego Conde-Royo, 293776

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER POST SOLID ORGAN TRANSPLANT – A HETEROGENOUS, AGGRESSIVE DISORDER: A MULTICENTRE REPORT

EHA Library, Laura Mcdonald, 293777

PLACE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH T-CELL LYMPHOMAS: PAVLOV UNIVERSITY RETROSPECTIVE STUDY

EHA Library, Elena Lepik, 293778

DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) AND THE RISK OF CENTRAL NERVOUS SYSTEM (CNS) RELAPSE: A REVIEW FROM THE RITUXIMAB (RTX) ERA

EHA Library, Joana Vieira, 293779

GENETICALLY DEFINED SUBTYPES OF DLBCL FROM TARGETED PANEL ON PLASMA MATCH PREVIOUSLY DESCRIBED TUMOR TISSUE SUBTYPES

EHA Library, Ehsan Tabari, 293781

VALUE OF GENETIC ANALYSIS FOR THE DIAGNOSTIC WORKFLOW OF MATURE CD5 NEGATIVE B-CELL NEOPLASMS ASSOCIATED WITH SPLENOMEGALY

EHA Library, Constance Baer, 293782

GENOME-WIDE CRISPR LIBRARY SCREENING IDENTIFIES GENETIC VULNERABILITIES AND THERAPEUTIC TARGETS IN ADULT T-CELL LEUKEMIA/LYMPHOMA

EHA Library, Takashi Ishio, 293783

ASSESSMENT OF CIRCULATING TUMOR DNA IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA: EARLY IDENTIFICATION OF PATTERN OF MUTATIONS ASSOCIATED WITH RESPONSE OR RESISTANCE TO PD-1 INHIBITORS

EHA Library, Carmelo Carlo-Stella, 293784

SINGLE-CELL RNA-SEQ REVEALS IMMUNE ESCAPE AND DRUG RESISTANCE MECHANISM OF MANTLE CELL LYMPHOMA

EHA Library, Liang Wang, 293785

TUMOR MICROENVIRONMENT AND ELEVATED IL6 ARE ASSOCIATED WITH SEVERE TOXICITY IN PATIENTS WITH LBL TREATED WITH AXICABTAGENE CILOLEUCEL

EHA Library, Rawan Faramand, 293786

SUCCESSFUL EMPLOYMENT OF SPATIAL IMAGING MASS CYTOMETRY IN FOLLICULAR LYMPHOMA CONFIRMS A CENTRAL ROLE OF FOLLICULAR HELPER T-CELLS IN DISEASE PATHOGENESIS AND HAS UTILITY IN PREDICTING OUTCOME

EHA Library, Elizabeth Phillips, 293787

STANDARDIZED 26-PARAMETER FLOW CYTOMETRY FACILITATES UNSUPERVISED WHO CLASSIFICATION OF B-CELL NON HODGKIN´S LYMPHOMA: RESULTS FROM A COMPREHENSIVE MULTICENTER ANALYSIS BY THE EUROFLOW CONSORTIUM

EHA Library, Sebastian Böttcher, 293788

CYCLIN D2 OVEREXPRESSION DRIVES B1-LIKE MURINE MANTLE CELL LYMPHOMA

EHA Library, Tim PIETERS, 293789

CD20-TCB INDUCES T-CELL ACTIVATION AND T-CELL-MEDIATED TUMOR CELL KILLING IN PATIENTS WITH RELAPSED OR REFRACTORY NON-HODGKIN LYMPHOMA: BIOMARKER RESULTS FROM A PHASE I STUDY

EHA Library, Ann-Marie E. Bröske, 293790

VALIDATION OF GENE EXPRESSION SIGNATURES IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Jessica Plaça, 293791

MUTATIONAL PROFILE IN NEWLY DIAGNOSED FOLLICULAR LYMPHOMA AND CORRELATION WITH OUTCOME AFTER TREATMENT WITH INMUNOCHEMOTHERAPY

EHA Library, Conchi Fernández Rodríguez, 293792